While the rate of HIV in Kampala, Uganda, is more than double the national average, a recent survey of displaced youths in the city found that only about 20% consistently used condoms and just half of the study participants ...
Mar 9, 2026
0
0
For people living with human immunodeficiency virus (HIV), life-saving antiretroviral therapy keeps their HIV-infected immune cells from making new copies of the virus, preventing illness and transmission. Historically, these ...
Mar 7, 2026
0
0
How people with compromised immune systems respond to vaccines is an important area of immunological research. A study led by York University has found that not only could machine-learning models accurately pinpoint differences ...
Mar 4, 2026
0
0
Modern HIV treatment is one of medicine's great success stories. With today's therapies, many people living with HIV can expect long, full lives. But as patients age, a new reality has emerged: The biggest threats to their ...
Mar 4, 2026
0
0
A growing number of states are rolling back financial help for HIV medications.
Mar 3, 2026
0
0
Long-acting antiviral medications are transforming HIV prevention and care, requiring only minimalistic dosing. But as the use of lenacapavir expands, scientists are probing a critical question: If the virus evolves resistance, ...
Monthly injections of long-acting cabotegravir-rilpivirine are superior to standard oral antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) and medication adherence challenges, according to a ...
Feb 27, 2026
0
0
A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could effectively replace more complicated HIV treatment regimens used by people living with HIV who are ...
Feb 25, 2026
0
0
A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the 2025 freeze on U.S. foreign assistance triggered disruptions to HIV services, medications, labs, ...
Feb 25, 2026
0
0
A new study has overcome a long-standing challenge: how to isolate and study elusive HIV-infected cells called authentic reservoir clones (ARCs) that evade the immune system, making the disease difficult to cure. Researchers ...
Feb 24, 2026
0
0
